Eculizumab 300 mg Injection bulk supplier for pharma manufacturers

Eculizumab 300 Mg Injection 300mg/30ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 300mg/30ml

Reference Brands: Bkemv (USA), Soliris (EU/LATAM)

Eculizumab injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell destruction or breakdown (hemolysis) in patients with PNH.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Eculizumab-aeeb is a highly targeted biologic medicine used in the treatment of rare complement-mediated disorders, particularly paroxysmal nocturnal hemoglobinuria (PNH). PNH is a rare genetic condition characterized by intermittent destruction of red blood cells due to uncontrolled activation of the complement system. The underlying cause of PNH is a deficiency of CD59, a natural complement inhibitor that normally protects red blood cells from the membrane attack complex (MAC). Without this protective mechanism, red blood cells are vulnerable to complement-mediated lysis, leading to anemia, fatigue, and other complications.

Eculizumab-aeeb works by specifically inhibiting complement protein C5, effectively preventing the formation of the MAC and reducing the destruction of red blood cells. This targeted mechanism helps control hemolysis, improves patient quality of life, and reduces the risk of complications associated with PNH. As a recombinant monoclonal antibody, Eculizumab-aeeb is produced using advanced biotechnology and is available in regulated markets across the United States, Europe, and other international regions. Its clinical effectiveness has made it a cornerstone therapy for patients living with this rare and life-impacting condition.

Eculizumab 300 Mg Injection — third party manufacturing & bulk supply

Eculizumab 300 Mg Injection 300mg/30ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Eculizumab 300 Mg Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Eculizumab 300 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Eculizumab 300 Mg Injection →

Back to Listing

Frequently Asked Questions

Eculizumab-aeeb is used for the treatment of rare and serious complement-mediated disorders. It is indicated for conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It works by inhibiting the complement protein C5, which helps prevent the destruction of red blood cells and reduces damage caused by uncontrolled complement system activation.

Eculizumab-aeeb is a recombinant monoclonal antibody produced using advanced biotechnology in genetically engineered cell lines. It is designed to specifically target and block complement component C5.

A commonly known trade name associated with this biosimilar is Bkemv.

Eculizumab-aeeb is manufactured by Amgen and distributed in regulated markets where biosimilar approvals are granted.

The generic name is Eculizumab-aeeb.

One of the well-known brand names is Bkemv. The reference product in this category is Soliris.

Eculizumab-aeeb is manufactured in regulated biopharmaceutical production facilities in countries such as the United States and other regions that follow strict biologics manufacturing and quality standards.